Treatment of substance P-related disorders
US6709651B2 · kind B2 · utility
1Cited by
14References
11Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2001 |
| Grant date | Mar 23, 2004 |
| Priority date | — |
| Expiry date | Jul 3, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed to methods of treating a wide variety of diseases, disorders and conditions characterized by excessive activity of substance P. The treatment involves administering peptidases that recognize and selectively cleave polypeptides at Xaa-Pro sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.